Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipating Freshpets Quarterly Earnings Report Analyst Projections and Investor Expectations

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
Investings on laptop and finances
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Freshpet (NASDAQ: FRPT) is gearing up to unveil its latest quarterly earnings report on February 26, 2024. Analysts are projecting an earnings per share (EPS) of $0.05 for the company. In the previous quarter, Freshpet exceeded expectations by $0.04, leading to a slight 0.31% decrease in the share price the following day.

Investors are eagerly anticipating Freshpet not only surpassing this estimate but also offering positive guidance for the next quarter. Stock prices are often more significantly influenced by guidance than by earnings beats or misses. As of February 22, the stock was trading at $90.29, marking a 49.33% increase over the past 52 weeks, showcasing promising returns that could enhance long-term investor confidence.

Freshpet’s track record of earnings performance has been a mixed bag, with some quarters exceeding EPS estimates and others falling short, resulting in corresponding price fluctuations. The company’s revenue has been on an upward trajectory year-over-year, and its earnings are forecasted to improve in the upcoming year, transitioning from a loss of ($1.00) per share to ($0.23) per share.

Analysts are predicting Freshpet to report an EPS of 9 cents for the fourth quarter, a significant improvement from a loss of 6 cents per share in the same quarter last year. Investors will be closely monitoring both the earnings outcomes and any guidance provided by Freshpet to assess the company’s future performance and potential stock price movements.

Freshpet Inc. (FRPT) Stock Surges 2.50% on Strong Performance in Market – February 23, 2024

On February 23, 2024, Freshpet Inc. (FRPT) had a strong performance in the stock market. The company’s stock was trading near the top of its 52-week range and was above its 200-day simple moving average, indicating positive price momentum.

The price of FRPT shares saw a significant increase of $2.26 since the market last closed, representing a 2.50% rise in the stock price. The stock opened at $90.29, inline with its previous close, but managed to gain momentum throughout the day and achieve a notable increase in its share price.

Overall, FRPT had a successful trading day on February 23, 2024, with positive price momentum and a significant rise in stock price. Investors who had invested in the company saw their investments grow as the stock performed well in the market. It will be interesting to see how FRPT continues to perform in the coming days and whether it can sustain this positive momentum.

FRPT Stock Performance Analysis on February 23, 2024: Revenue Growth but Declining Net Income

On February 23, 2024, FRPT stock showed some interesting performances based on the data provided by CNN Money. The total revenue for the company was $595.34 million over the past year, which increased by 39.92% compared to the previous year. In the most recent quarter, the total revenue was $200.62 million, showing a 9.43% increase from the previous quarter.

However, despite the growth in revenue, the net income for FRPT was not as positive. The net income for the past year was -$59.49 million, indicating a significant decrease of 100.32% from the previous year. In the most recent quarter, the net income was -$7.17 million, showing a 57.73% increase from the previous quarter.

Earnings per share (EPS) for FRPT also saw some fluctuations. The EPS for the past year was -$1.29, which decreased by 86.18% compared to the previous year. In the most recent quarter, the EPS was -$0.15, showing a 57.78% increase from the previous quarter.

Overall, these financial indicators suggest a mixed performance for FRPT stock on February 23, 2024. Investors may want to closely monitor the company’s financial health and future performance to make informed decisions about their investment in FRPT stock.

Tags: FRPT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare cloud based

Select Healthcare Corporation Reports Impressive Q4 Results and Approves 108 Billion Buyback Program

Mining Stock Market Today

AngloGold Ashanti Reports Strong Financial Results and New Gold Discovery in FY23

Electric Utilities Stock Exchange

TransAlta Reports Strong Q4 Earnings and Launches Share Buyback Program

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com